Advertisement

TheBodyPRO.com Covers CROI 2017

News

Early Diagnosis and Treatment in Infants Is Challenging

By Barbara Jungwirth

From TheBodyPRO

March 8, 2017

Even if we have the best drug, it cannot do anything if we don't have all [the social] aspects together.

-- Bindiya Meggi, M.Sc.

In an interview on behalf of IFARA at CROI 2017, Natella Rakhmanina spoke with Hermione Lyall, Jintanat Ananworanich and Bindiya Meggi about HIV in infants. Immediate diagnosis and early treatment provide the best chance for achieving remission of the virus in infants. Yet, in resource-limited settings, central processing of HIV tests may delay results for several months after birth.

Mozambique therefore studied a point-of-care device that provides same-day HIV test results (HIV+/HIV- only). Clinics using the device saw a seven-fold increase in the number of children on HIV treatment and 20% better retention in care three months later compared with the standard of care in the country.

While better drugs for very young infants are desirable, support for their mothers and community education about the importance of treatment are needed for these medications to have the desired effect. Even with better prevention of HIV transmission at birth, some infants may have seroconverted in utero months earlier. Thus, treatment right after birth may not start early enough in these babies.

Watch the video to learn more:



About the panelists:

  • Natella Rakhmanina, M.D., Ph.D., George Washington University, Washington, D.C.; moderator.
  • Hermione Lyall, M.D., MRCP, FRCPCH, Imperial College Healthcare NHS Trust, London, United Kingdom.
  • Jintanat Ananworanich, M.D., Ph.D., U.S. Military HIV Research Program.
  • Bindiya Meggi, M.Sc., Instituto Nacional de Saúde Moçambique, Mozambique.

The video above has been posted on TheBodyPRO.com with permission from our partners at the International Foundation for Alternative Research in AIDS (IFARA). Visit IFARA's website or YouTube channel to watch more video interviews from the conference, as well as earlier meetings.

Barbara Jungwirth is a freelance writer and translator based in New York.

Follow Barbara on Twitter: @reliabletran.


Related Stories

Starting HIV Treatment Within 6 Months of Birth Linked to Sustained Viral Suppression
Community Engagement in HIV Prevention Is a Disaster Management Plan
The Need to Advocate for Fair HIV Drug Prices



This article was provided by TheBodyPRO. It is a part of the publication The 24th Conference on Retroviruses and Opportunistic Infections.
 

No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:


Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.

Advertisement

The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.